NervGen Pharma Corp Reports Q2 Financial Results and Shareholder Update
NervGen Pharma Corp releases second-quarter financial results and provides a letter to shareholders, highlighting progress…
Mon. Sep 8th, 2025
Trending
Africa’s Renewable Energy Revolution Gains Momentum
Europe Travel Alert: Schengen Area Faces Security Concerns and Border Delays
Revolutionizing Healthcare: Medtronic’s AI-Powered Pulse Technology
Guyana’s Oil Fund Sees Significant Boost with $618 Million in Q2 2025
Uncovering the Truth: Land Surveyor Controversy at Zambrano Campus